The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 25, 2025
Filed:
Mar. 04, 2019
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Kristof Van Kolen, Haacht, BE;
Marc Mercken, Turnhout, BE;
Linda Barone, Exton, PA (US);
Eilyn R. Lacy, Lansdowne, PA (US);
Rupesh Nanjunda, Hatfield, PA (US);
John Wheeler, Downington, PA (US);
Jinquan Luo, Malvern, PA (US);
Marianne Borgers, Balen, BE;
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); C12N 15/62 (2006.01); C12N 15/85 (2006.01); G01N 33/563 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); C12N 15/62 (2013.01); C12N 15/85 (2013.01); G01N 33/563 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2835 (2013.01);
Abstract
Monoclonal anti-tau antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies and using the antibodies for treating or preventing conditions such as tauopathies. The antibodies of the invention may also be used to quantify tau in biological samples.